Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
343 Leser
Artikel bewerten:
(1)

Lyfegen platform supports Johnson & Johnson to further drive value-based healthcare strategy

BASEL, Switzerland, Aug. 3, 2021 /PRNewswire/ -- Lyfegen announces that its value-based healthcare contracting platform has been implemented together with Johnson & Johnson Medical Devices Companies Switzerland (Johnson & Johnson) and a leading Swiss Hospital.

The Lyfegen Platform paves the way for value-based healthcare.

Through this?new value-based healthcare approach,?Lyfegen?and its partners drive the shift towards what matters most to patients: improved patient health outcomes and more efficient use of financial and human resources, enabling a sustainable post-COVID-19 healthcare environment.??

The?shift towards a?value-based healthcare in Switzerland and globally can only be achieved through the support of innovative technologies. Lyfegen's?platform?is a key enabler for this transition. The platform digitalises?and automates the execution of?value-based healthcare agreements, paving the way for the resource-efficient scaling of such novel agreements.???

"COVID-19 has shown us the urgent need for a more sustainable healthcare system. With?the?implementation of value-based healthcare?agreements on the?Lyfegen?platform, we are extremely proud to help?Johnson & Johnson?and hospitals to accelerate the transition to value-based healthcare and improve patient health outcomes at reduced cost."?says?Lyfegen's?CEO, Girisha Fernando??

Lyfegen's?compliant, secure and patent-protected value-based healthcare contracting platform automates the collection and analysis of patient-level data. Users receive transparency on actionable health outcomes and agreement performance. Lyfegen's?contribution to this partnership is a blueprint for the scaling of value-based healthcare models across hospitals, health insurances, medical device & pharma companies globally. The partnership marks another important milestone for?Lyfegen, as the company continues to grow and has recently opened its next investment round.??

About?Lyfegen??

Lyfegen?HealthTech AG was founded in 2018 by Girisha Fernando, Michel Mohler and Nico Mros to improve the life of every patient by driving the shift to value-based healthcare. With its patent-protected software-as-a-service platform,?Lyfegen?enables hospitals, health insurances, medical device and pharma companies to implement and scale value-based healthcare agreements to improve access, patient health outcomes and increase affordability.??

Lyfegen

Related Links:
https://www.lyfegen.com?
Linkedin: https://www.linkedin.com/company/lyfegenhealth

Contact Press:?press@lyfegen.com
Contact Investors: investors@lyfegen.com

Photo - https://mma.prnewswire.com/media/1586295/Lyfegen_Platform.jpg
Logo - https://mma.prnewswire.com/media/1586294/Lyfegen_Logo.jpg

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.